The design firm was tasked with creating a classic, elegant brand identity that communicated a sense of quality and tradition. According to NXL Design, the packaging design aesthetics were developed to create a theme that is relevant to the ...
Tags: packaging, NXL, packaging design
Domain Therapeutics SA announced today that Domain Therapeutics grants Prexton Therapeutics an exclusive option to license and develop metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting ...
Tags: Domain Therapeutics SA, chemical, drugs
Pro Mach Inc. has formed a new End of Line (EOL) Distributed Products Group to enhance sales and marketing support for distributors selling its end of line products. Pro Mach's EOL brands primarily sold through specialty packaging ...
New research from Mayo Clinic and Banner Sun Health Research Institute has demonstrated that testing a portion of saliva gland could be a way to diagnose Parkinson's disease. The study, which enrolled 15-patient, collected biopsies from ...
Amarantus BioScience has purchased all of the intellectual property (IP) assets from Power3 Medical Products. Power3 was in bankruptcy and the company has acquired the IP assets for $40,000 which includes technology related to the ...
Tags: Amarantus BioScience, intellectual property, Power3 Medical Products
Medical researchers at the University of Melbourne have made a discovery that could lead to a simple blood test for Creutzfeldt-Jakob Disease (CJD) and Mad Cow disease. Using genetic sequencing, the scientists found that cells infected ...
UCL has entered into a collaborating agreement with Eisai to identify, validate and develop new therapeutics for treating neurological diseases such as Alzheimer's, Parkinson's and other related disorders. The collaboration will also ...
Tags: neurological disease, collaboration, therapeutics, clinical trial
Navidea Biopharmaceuticals has entered into an agreement to license Alseres Pharmaceuticals' Iodine-123 radiolabeled imaging agent, [123I]-E-IACFT Injection (CFT). The patented small molecule radiopharmaceutical imaging agent, which ...
The European Union (EU) has granted CE mark to Boston Scientific's deep brain stimulator to treat Parkinson's disease. The Vercise deep brain stimulator, which includes multiple independent current control, uses electrical signals to ...
Tags: Parkinson, Vercise, deep brain stimulator, Wurzburg neurology department
Specialty pharmaceutical company Cynapsus Therapeutics has received a Notice of Allowance from the US Patent and Trademark Office (USPTO) for a patent application No. 13/445,656 that covers APL-130277. Fast-acting APL-130277 is a thin ...
NXL Design and its partner National Flexible have combined to create the new packaging for Spar’s savoury snack range The project for the retailer took six weeks with NXL overseeing the creative development of branded packaging ...
Bicycles Plus owner John Crews marked his shop's silver anniversary in unusual fashion: He completely overhauled his already successful 25-year-old business. Earlier this year, the longtime Specialized and Trek dealer had come to a ...
Tags: shop's silver anniversary, Bicycles Plus, Bicycle Products
The European Union has granted CE mark approval to InSightec's transcranial focused ultrasound system for the treatment of essential tremor, tremor dominant Parkinson's disease and neuropathic pain. The non-invasive ExAblate Neuro ...
Tags: transcranial focused ultrasound system, Parkinson's disease
Novartis has obtained the US Food and Drug Administration (FDA) approval for a new 13.3 mg/24 h dosage strength of its Exelon Patch (rivastigmine transdermal system), designed to treat patients with mild to moderate Alzheimer's disease. ...
Tags: Alzheimer's disease, Novartis Pharmaceuticals, Exelon Patch
Health and Disability Ethics Committee of the New Zealand Ministry of Health has granted ethical approval for Living Cell Technologies' (LCT) Phase I Parkinson's disease trials of NTCELL. The company won regulatory authorisation to ...
Tags: ethical approval, Parkinson's disease trials, clinical study